Stay updated on Prophylactic Emicizumab in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.

Latest updates to the Prophylactic Emicizumab in Hemophilia A Clinical Trial page
- Check4 days agoChange DetectedNew navigation items were added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and a recruitment status note (No longer looking for participants). The page also shows an updated revision tag (Revision: v3.6.0).SummaryDifference0.3%

- Check11 days agoChange DetectedRevision: v3.5.5 replaces the prior v3.5.4, indicating a small version update to the page's metadata rather than substantive content changes.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's metadata or content rather than any substantive changes to study details or results.SummaryDifference0.0%

- Check47 days agoChange Detected- Revision updated from v3.5.2 to v3.5.3 to reflect an update to the page’s version; it does not alter the study details or content.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.5.2 added; Revision: v3.5.0 removed.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded 'Hereditary factor VIII deficiency disease' as a related disease term and included a link to the Genetic and Rare Diseases Information Center (GRDR) for further information.SummaryDifference0.1%

Stay in the know with updates to Prophylactic Emicizumab in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prophylactic Emicizumab in Hemophilia A Clinical Trial page.